financetom
Business
financetom
/
Business
/
Preview: High Roller Technologies, Inc Set To IPO Tomorrow
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Preview: High Roller Technologies, Inc Set To IPO Tomorrow
Oct 15, 2024 8:31 AM

High Roller Technologies, Inc ( ROLR ) IPO will take place October, 16 on the NYSE exchange under the ticker ROLR.

The company is offering shares at an expected price between $8.00 and $10.00 per share with an insider lock-up period of 180 days ending on April 14, 2025.

See also: Benzinga IPO Calendar

About High Roller Technologies, Inc

High Roller Technologies, Inc. ( ROLR ) is an evolving and growth-oriented global online gaming operator. We offer a compelling real money online casino platform.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Beigene's Cancer Drug Tevimbra Recommended by EU Panel for Extension of Indication
Beigene's Cancer Drug Tevimbra Recommended by EU Panel for Extension of Indication
May 26, 2025
10:13 AM EDT, 05/23/2025 (MT Newswires) -- The European Medicines Agency's Committee for Medicinal Products for Human Use said Friday it recommended an extension of therapeutic indication for Beigene's ( ONC ) cancer drug Tevimbra. Tevimbra is already authorized in the EU, the committee said, with indications for non-small cell lung cancer, gastric or gastroesophageal junction adenocarcinoma, and oesophageal squamous...
EU awaits clarity on Trump's 50% tariff threat
EU awaits clarity on Trump's 50% tariff threat
May 26, 2025
BRUSSELS (Reuters) -The European Commission sought clarity from the United States after U.S. President Donald Trump recommended on Friday putting a 50% tariff on EU imports from June 1, with Brussels' and Washington's trade chiefs due to talk later. The Commission, which oversees trade policy for the 27-nation European Union, said it would not comment on the tariff threat until...
Frontline CEO Says Tanker Industry 'Maintains Business As Usual' Amid Uncertainty
Frontline CEO Says Tanker Industry 'Maintains Business As Usual' Amid Uncertainty
May 26, 2025
Frontline Plc ( FRO ) shares are trading higher on Friday. The company reported revenue of $427.9 million, surpassing the $264.2 million consensus. Adjusted EPS declined to 18 cents from 62 cents a year ago, missing the consensus of 23 cents. The company’s reported spot time charter equivalent earnings (TCEs) for VLCCs, Suezmax tankers, and LR2/Aframax tankers were $37,200 (vs. $48,100 last year), $31,200 (vs. $45,800 last year)...
Copyright 2023-2026 - www.financetom.com All Rights Reserved